Results 91 to 100 of about 176,716 (160)

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity. [PDF]

Front Cardiovasc Med
Pala B, Piscione M, Di Marcantonio MC, Cribari F, Vitale R, Baldi T, Popolo A, Mincione G.   +7 more
europepmc   +1 more source

In Silico and in vitro antiviral activity of FDA approved drugs from ZINC database against RNA-dependent RNA polymerase of dengue virus. [PDF]

Virol J
Uzma A, Adiba, Kausar A, Aslam MW, Ali L, Ali M, Qazi AS, Haq A, Amraiz D, Sindi ER, Alqahtani T, Zaki MEA, Assefa M.   +12 more
europepmc   +1 more source

Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan. [PDF]

Breast Cancer (Dove Med Press)
Chen YC, Cheng MC, Chen PH, Chung CH, Chien WC, Dai MS, Chen JH, Huang TC.   +7 more
europepmc   +1 more source

Doxorubicin induces ferroptosis in endometrial cancer by suppressing the MKK6/p38/CEBPB axis. [PDF]

J Transl Med
Zhang J, Wang Z, Li Y, Zhao P, Ren D, Lu X.   +5 more
europepmc   +1 more source

Discovery of an Endonuclease G-inhibitory Ku80-peptide protecting against leukemogenic rearrangements at the MLL breakpoint cluster. [PDF]

Nat Commun
Eberle J, Salem A, Hofmann M, Reisser A, Ruiz-Blanco YB, Almeida-Hernandez Y, Gole B, Rall-Scharpf M, Angulo-Capel J, Monecke T, Sanchez-Garcia E, Gebhardt JCM, Wiesmüller L.   +12 more
europepmc   +1 more source

The CHK1 inhibitor Prexasertib is effective against <i>in vitro</i> models of aggressive thyroid carcinomas with defective p53 function. [PDF]

Front Endocrinol (Lausanne)
Manzo A, Grassi ES, Borghi MO, Colombo C, Persani L, Cirello V.   +5 more
europepmc   +1 more source

Liposomal doxorubicin plus nab-paclitaxel with/without chemoradiotherapy in head and neck adenoid cystic carcinoma: single-arm phase II study. [PDF]

Signal Transduct Target Ther
Zhang X, Wei J, Chen N, Liu K, Liang R, Ma L, Song Z, Gu X, Chen X, Yang S.   +9 more
europepmc   +1 more source

Fibroblast Activation Protein Alpha-Targeted Nanoparticles for Tumor Microenvironment Remodeling and Antitumor Therapy in Triple-Negative Breast Cancer. [PDF]

Biomater Res
Lameirinhas A, Díez P, Hicke FJ, Ágreda-Roca A, Torres-Ruiz S, Sánchez-Serrano P, Tapia M, Lluch A, Bermejo B, Cejalvo JM, Martínez-Máñez R, Eroles P, Garrido-Cano I.   +12 more
europepmc   +1 more source

Cardiomyocyte Stim1 Deficiency Exacerbates Doxorubicin Cardiotoxicity by Magnification of Endoplasmic Reticulum Stress [Retraction]. [PDF]

J Inflamm Res
europepmc   +1 more source